Ph.D., CTO, Karius
Biography
Sivan Bercovici is the Chief Technology Officer at Karius, where he leads the computational and data efforts aimed at unlocking the clinical value in the microbiome data. Throughout his career, Sivan has developed novel machine-learning methods and analytical platforms that address broad challenges in genetics and the study of human disease. Prior to Karius, Sivan was a co-founder and Chief Technology Officer at Lifecode. He obtained his Ph.D. in Computer Science from Technion - Israel Institute of Technology and completed his postdoctoral research at Stanford University, as part of Stanford’s Artificial Intelligence Laboratory.
Talk
Clinical Dx Showcase:
Karius
Karius sees a world where infectious disease is no longer a major threat to human health. With the Karius Test®, we deliver unprecedented diagnostic insight to enable physicians to make rapid treatment decisions.
Liquid biopsy into the microbial world
Microbial cfDNA: Novel chemistries, data, and ML provide unprecedented and unbiased access to unique microbial profiles.
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S2 - January 25 9.00 A.M.-1.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-4.45 P.M.,Showcase Track S2 - January 27 9.00 A.M.-2.15 P.M.
The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative
